微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 19.54% | -10.89% | 5.11% | 46/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 18.59% | -19.61% | 10.8% | 47/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 16.78% | -30.72% | 31.42% | 44/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 12.76% | -49.4% | -41.78% | 47/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 21.92% | -29.52% | -5.18% | 43/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 23.12% | -27.98% | -4.51% | 43/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 24.21% | -29.23% | -4.02% | 39/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 25.23% | 0.14% | -18.9% | 43/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 31.1% | 6.95% | -3.11% | 39/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 32.1% | 9.1% | -6.17% | 40/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 34.21% | 21.46% | 35.82% | 36/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 25.19% | -11.95% | -13.38% | 46/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 29.08% | 0.21% | -1.16% | 38/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 29.42% | 13.67% | 4.46% | 40/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 28.17% | 25.77% | -1.54% | 35/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 28.61% | 17.39% | -1.43% | 44/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 29.02% | 4.77% | 12.11% | 34/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 25.89% | -3.02% | 15.58% | 42/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 22.4% | 2.95% | -8.1% | 28/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 24.37% | 3.88% | -12.02% | 45/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 27.7% | -18.09% | 3.77% | 29/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 26.69% | -27.36% | 22.7% | 31/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 21.75% | -40.95% | -7.27% | 25/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 23.46% | -12.74% | -30.63% | 46/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 33.82% | -32.84% | -7.98% | 23/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 36.75% | -28.1% | -0.26% | 24/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 36.84% | -31.23% | 37.04% | 18/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 26.88% | -43.55% | -46.61% | 43/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 50.35% | 3.69% | -1.48% | 7/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 51.11% | 11.08% | -4.6% | 10/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 53.57% | 28.22% | 12.48% | 10/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 47.63% | 29.69% | -1.93% | 10/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 48.56% | 50.46% | 5.55% | 9/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 46.01% | 49.57% | 10.12% | 13/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 41.78% | -10.87% | 13.77% | 11/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 36.72% | 77.7% | 13.78% | 20/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 32.28% | 72.7% | 4.92% | 15/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 30.76% | 71.93% | -34.38% | 17/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 46.88% | 99.18% | 126.83% | 4/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |